retatrutide patent owner retatrutide patent owner Pharmaceutical Patent

The #obesity drug market continues to attract major investment, and AstraZeneca is clearly positioning itself to compete at scale

Nevertheless, the team did emphasize that the short follow-up period in their study may be insufficient to fully capture the chronic trajectory of glaucoma development, particularly given the recent FDA approval of tirzepatide

Weight Loss Surgery Its possible to take a weight loss drug instead of surgery, Norris said

In this article, Alessandra (Ale) Vignola, President of Cardiovascular & Metabolic, explores the need for sustainable, patient-first solutions in GLP-1 clinical trials from personalized approaches to behavioral and social support

Set an alarm on your phone so you're sure not to miss your injection date

This has not been examined in subgroup analyses